A statement from the Bionical Emas Group on guidance & measures regarding COVID-19 - read here

In relation to staff and visitor safety, we have full risk assessments in place for all of our workplaces. These risk assessments are revisited and updated regularly, to reflect changing risks, knowledge and circumstances, and to reflect evolving Government guidance. We have not placed the risk assessments here on the website as they would become out of date too quickly. However, you are welcome to email info@bionical-emas.com to request access to our most up to date risk assessments applicable to your needs. Please note that all our staff are notified of all applicable risk assessments and updates, along with ‘quick guides’ automatically via our e-learning system.

HomeClinical Development

Clinical
Development.

At Bionical Emas we understand that individual biotech and pharma companies have very different needs. All our clinical development services can be tailored to meet those individual requirements. From a standalone service, to a fully integrated large global clinical trial, the Bionical Emas team, has the expertise and experience to support and deliver our clients clinical development plans.

The Bionical Emas difference is that ‘To Care’ is part of our culture and founding philosophy. We care about delivering for our clients, the investigator sites with which we work every day and we care about the patients whom we ultimately serve. We care about the quality of the work we produce, and we care that our staff are supported, so they deliver the best they can, each and every day. Contact us and let Bionical Emas care for your clinical development plans.

How can we support you?

Our dedicated teams of experts are on hand to help should you require any additional resource or further information about our services.